Outcome after single dose of ChAdOx1 vaccine against SARS-CoV-2 infection at 16 weeks post-vaccination among healthy adults in Saudi Arabia

BACKGROUND: The rate of severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) infection and immunogenicity of a single dose of ChAdOx1 vaccine at 16 weeks post-vaccination among young and healthy participants remains unclear in Saudi Arabia. OBJECTIVES: Assess the rate of subsequent infection...

Descripción completa

Detalles Bibliográficos
Autores principales: Alghamdi, Ahlam, Alsanea, Nasser, Alraey, Mohammed, Joseph, Mercy, Aboud, Mohammed, Almangour, Thamer, Alharbi, Wasaef, Alhumidan, Hind, Alanizi, Abdalrhman, Al-jedai, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: King Faisal Specialist Hospital and Research Centre 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357300/
https://www.ncbi.nlm.nih.gov/pubmed/35933607
http://dx.doi.org/10.5144/0256-4947.2022.223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357300/
https://www.ncbi.nlm.nih.gov/pubmed/35933607
http://dx.doi.org/10.5144/0256-4947.2022.223

Ejemplares similares